Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2013 (2013), Article ID 349782, 5 pages
http://dx.doi.org/10.1155/2013/349782
Review Article

Unsolved Issues in the Management of High Blood Pressure in Acute Ischemic Stroke

Department of Neurology and Neurological Intensive Medicine, Klinikum Harlaching, Städtisches Klinikum München GmbH, Thalkirchner Straße 48, 80337 Munich, Germany

Received 22 March 2013; Accepted 3 April 2013

Academic Editor: Blas Gil Extremera

Copyright © 2013 Gordian J. Hubert et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Leonardi-Bee, P. M. W. Bath, S. J. Phillips, and P. A. G. Sandercock, “Blood pressure and clinical outcomes in the International Stroke Trial,” Stroke, vol. 33, no. 5, pp. 1315–1320, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Britton, A. Carlsson, and U. De Faire, “Blood pressure course in patients with acute stroke and matched controls,” Stroke, vol. 17, no. 5, pp. 861–864, 1986. View at Google Scholar · View at Scopus
  3. U. Fischer and P. M. Rothwell, “Blood pressure management in acute stroke,” Stroke, vol. 42, no. 10, pp. 2995–2998, 2011. View at Google Scholar
  4. E. C. Jauch, J. L. Saver, H. P. Adams Jr. et al., “Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association,” Stroke, vol. 44, no. 3, pp. 870–947, 2013. View at Google Scholar
  5. European Stroke Organisation (ESO) Executive Committee and ESO Writing Committee, “Guidelines for management of ischaemic stroke and transient ischaemic attack 2008,” Cerebrovascular Diseases, vol. 25, no. 5, pp. 457–507, 2008. View at Publisher · View at Google Scholar
  6. The ENOS Trial Investigators, “Glyceryl trinitrate versus control, and continuing versus stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122),” International Journal of Stroke, vol. 1, no. 4, pp. 245–249, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. “ENCHANTED,” http://clinicaltrials.gov/ct2/show/NCT01422616.
  8. K. N. Vemmos, G. Tsivgoulis, K. Spengos et al., “U-shaped relationship between mortality and admission blood pressure in patients with acute stroke,” Journal of Internal Medicine, vol. 255, no. 2, pp. 257–265, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Willmot, J. Leonardi-Bee, and P. M. W. Bath, “High blood pressure in acute stroke and subsequent outcome: a systematic review,” Hypertension, vol. 43, no. 1, pp. 18–24, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. Q. J. Durward, R. F. Del Maestro, A. L. Amacher, and J. K. Farrar, “The influence of systemic arterial pressure and intracranial pressure on the development of cerebral vasogenic edema,” Journal of Neurosurgery, vol. 59, no. 5, pp. 803–809, 1983. View at Google Scholar · View at Scopus
  11. S. A. Mayer, C. E. Thomas, and B. E. Diamond, “Asymmetry of intracranial hemodynamics as an indicator of mass effect in acute intracerebral hemorrhage: a transcranial Doppler study,” Stroke, vol. 27, no. 10, pp. 1788–1792, 1996. View at Google Scholar · View at Scopus
  12. J. Treib, S. C. Becker, M. T. Grauer, and A. Haass, “Transcranial Doppler monitoring of intracranial pressure therapy with mannitol, sorbitol and glycerol in patients with acute stroke,” European Neurology, vol. 40, no. 4, pp. 212–219, 1998. View at Google Scholar · View at Scopus
  13. T. Hrafnkelsdóttir, U. Wall, C. Jern, and S. Jern, “Impaired capacity for endogenous fibrinolysis in essential hypertension,” The Lancet, vol. 352, no. 9140, pp. 1597–1598, 1998. View at Google Scholar · View at Scopus
  14. T. Hrafnkelsdóttir, T. Gudnason, U. Wall, C. Jern, and S. Jern, “Regulation of local availability of active tissue-type plasminogen activator in vivo in man,” Journal of Thrombosis and Haemostasis, vol. 2, no. 11, pp. 1960–1968, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. L. S. Sjögren, R. Doroudi, L. M. Gan, L. Jungersten, T. Hrafnkelsdóttir, and S. Jern, “Elevated intraluminal pressure inhibits vascular tissue plasminogen activator secretion and downregulates its gene expression,” Hypertension, vol. 35, no. 4, pp. 1002–1008, 2000. View at Google Scholar · View at Scopus
  16. A. Chamorro, N. Vila, C. Ascaso, E. Elices, W. Schonewille, and R. Blanc, “Blood pressure and functional recovery in acute ischemic stroke,” Stroke, vol. 29, no. 9, pp. 1850–1853, 1998. View at Google Scholar · View at Scopus
  17. H. Christensen, G. Boysen, H. H. Johannesen, E. Christensen, and K. Bendtzen, “Deteriorating ischaemic stroke: cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke,” Journal of the Neurological Sciences, vol. 201, no. 1-2, pp. 1–7, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. H. P. Mattle, L. Kappeler, M. Arnold et al., “Blood pressure and vessel recanalization in the first hours after ischemic stroke,” Stroke, vol. 36, no. 2, pp. 264–268, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Oliveira-Filho, S. C. S. Silva, C. C. Trabuco, B. B. Pedreira, E. U. Sousa, and A. Bacellar, “Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset,” Neurology, vol. 61, no. 8, pp. 1047–1051, 2003. View at Google Scholar · View at Scopus
  20. J. Castillo, R. Leira, M. M. García, J. Serena, M. Blanco, and A. Dávalos, “Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome,” Stroke, vol. 35, no. 2, pp. 520–527, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. D. H. Barer, J. M. Cruickshank, S. B. Ebrahim, and J. R. Mitchell, “Low dose beta blockade in acute stroke (“BEST” trial): an evaluation,” British Medical Journal, vol. 296, no. 6624, pp. 737–741, 1988. View at Google Scholar
  22. J. P. Mohr, J. M. Orgogozo, M. J. G. Harrison et al., “Meta-analysis of oral nimodipine trials in acute ischemic stroke,” Cerebrovascular Diseases, vol. 4, no. 3, pp. 197–203, 1994. View at Google Scholar
  23. N. G. Wahlgren, D. G. MacMahon, J. de Keyser, B. Indredavik, and T. Ryman, “Intravenous nimodipine West European stroke trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke,” Cerebrovascular Diseases, vol. 4, no. 3, pp. 204–210, 1994. View at Google Scholar
  24. N. Ahmed, P. Näsman, and N. G. Wahlgren, “Effect of intravenous nimodipine on blood pressure and outcome after acute stroke,” Stroke, vol. 31, no. 6, pp. 1250–1255, 2000. View at Google Scholar · View at Scopus
  25. IMAGES Investigators, “Magnesium for acute stroke: randomised controlled trial,” The Lancet, vol. 363, pp. 439–445, 2004. View at Google Scholar
  26. P. M. W. Bath, R. Pathansali, R. Iddenden, and F. J. Bath, “The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke,” Cerebrovascular Diseases, vol. 11, no. 3, pp. 265–272, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Rashid, C. Weaver, J. Leonardi-Bee, F. Bath, S. Fletcher, and P. Bath, “The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke,” Journal of Stroke and Cerebrovascular Diseases, vol. 12, no. 3, pp. 143–151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. J. F. Potter, T. G. Robinson, G. A. Ford et al., “Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial,” The Lancet Neurology, vol. 8, no. 1, pp. 48–56, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. T. G. Robinson, J. F. Potter, G. A. Ford et al., “Effects of antihypertensive treatment after acute stroke in the continue or stop post-stroke antihypertensives collaborative study (COSSACS): a prospective, randomised, open, blinded-endpoint trial,” The Lancet Neurology, vol. 9, no. 8, pp. 767–775, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. E. C. Sandset, P. M. W. Bath, G. Boysen et al., “The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial,” The Lancet, vol. 377, no. 9767, pp. 741–750, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. C. M. Geeganage and P. M. W. Bath, “Relationship between therapeutic changes in blood pressure and outcomes in acute stroke: a metaregression,” Hypertension, vol. 54, no. 4, pp. 775–781, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Geeganage and P. M. Bath, “Interventions for deliberately altering blood pressure in acute stroke,” Cochrane Database of Systematic Reviews, no. 4, p. CD000039, 2008. View at Google Scholar · View at Scopus
  33. C. Geeganage and P. M. Bath, “Vasoactive drugs for acute stroke,” Cochrane Database of Systematic Reviews, vol. 7, p. CD002839, 2010. View at Google Scholar · View at Scopus
  34. K. R. Lees, E. Bluhmki, R. von Kummer et al., “Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials,” The Lancet, vol. 375, no. 9727, pp. 1695–1703, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. E. C. Sandset, G. D. Murray, P. M. W. Bath, S. V. Kjeldsen, E. Berge, and On behalf of the Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group, “Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome,” Stroke, vol. 43, no. 8, pp. 2108–2114, 2012. View at Google Scholar
  36. M. Willmot, A. Ghadami, B. Whysall, W. Clarke, J. Wardlaw, and P. M. W. Bath, “Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke,” Hypertension, vol. 47, no. 6, pp. 1209–1215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. G. M. Sare, L. J. Gray, J. Wardlaw, C. Chen, and P. M. W. Bath, “Is lowering blood pressure hazardous in patients with significant ipsilateral carotid stenosis and acute ischaemic stroke? Interim assessment in the 'Efficacy of Nitric Oxide in Stroke' Trial,” Blood Pressure Monitoring, vol. 14, no. 1, pp. 20–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. W. J. Powers, T. O. Videen, M. N. Diringer, V. Aiyagari, and A. R. Zazulia, “Autoregulation after ischaemic stroke,” Journal of Hypertension, vol. 27, no. 11, pp. 2218–2222, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. F. S. Nazir, J. R. Overell, A. Bolster, T. E. Hilditch, and K. R. Lees, “Effect of perindopril on cerebral and renal perfusion on normotensives in mild early ischaemic stroke: a randomized controlled trial,” Cerebrovascular Diseases, vol. 19, no. 2, pp. 77–83, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. G. M. Sare, L. J. Gray, and P. M. W. Bath, “Effect of antihypertensive agents on cerebral blood flow and flow velocity in acute ischaemic stroke: systematic review of controlled studies,” Journal of Hypertension, vol. 26, no. 6, pp. 1058–1064, 2008. View at Publisher · View at Google Scholar · View at Scopus